These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Aberrant expression of major histocompatibility complex class II antigen in inflammatory myopathies]. Kojima S, Takagi A. Rinsho Shinkeigaku; 1993 Jun; 33(6):612-9. PubMed ID: 8403680 [Abstract] [Full Text] [Related]
11. Activation of MHC-restricted rat T cells by cloned syngeneic thyrocytes. Hirose W, Lahat N, Platzer M, Schmitt S, Davies TF. J Immunol; 1988 Aug 15; 141(4):1098-102. PubMed ID: 2899600 [Abstract] [Full Text] [Related]
15. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes. Herkel J, Jagemann B, Wiegard C, Lazaro JF, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse AW. Hepatology; 2003 May 15; 37(5):1079-85. PubMed ID: 12717388 [Abstract] [Full Text] [Related]
17. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide. Zechel MA, Chaturvedi P, Lee-Chan EC, Rider BJ, Singh B. J Immunol; 1996 Jun 01; 156(11):4232-9. PubMed ID: 8666792 [Abstract] [Full Text] [Related]
19. Viral peptide specific induction of MHC class II expression by murine T cell clones. Thomas DB, Smith CA, Graham CM. J Immunol; 1996 Sep 15; 157(6):2386-94. PubMed ID: 8805637 [Abstract] [Full Text] [Related]
20. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2. Chen PW, Ananthaswamy HN. J Immunol; 1993 Jul 01; 151(1):244-55. PubMed ID: 8326126 [Abstract] [Full Text] [Related] Page: [Next] [New Search]